In this randomized , positive - and placebo-controlled crossover study , healthy men received a single dose of naloxegol @ mg ( therapeutic dose ) , naloxegol @ mg ( supratherapeutic dose ) , moxifloxacin @ mg ( positive control ) , or placebo in @ of @ sequences ( Williams Latin square design ) .